About the Authors
- Tamara Maes
-
Roles Conceptualization, Formal analysis, Funding acquisition, Project administration, Visualization, Writing – original draft, Writing – review & editing
* E-mail: tmaes@oryzon.com
Affiliation Oryzon Genomics, S.A., Cornellà de Llobregat, Spain
- Cristina Mascaró
-
Roles Formal analysis, Investigation, Methodology, Supervision, Validation, Writing – original draft, Writing – review & editing
Affiliation Oryzon Genomics, S.A., Cornellà de Llobregat, Spain
- David Rotllant
-
Roles Formal analysis, Investigation, Supervision, Visualization, Writing – original draft, Writing – review & editing
Affiliation Oryzon Genomics, S.A., Cornellà de Llobregat, Spain
- Michele Matteo Pio Lufino
-
Roles Formal analysis, Investigation, Methodology, Validation, Writing – original draft
Affiliation Oryzon Genomics, S.A., Cornellà de Llobregat, Spain
- Angels Estiarte
-
Roles Investigation, Supervision, Writing – review & editing
Current Address: Verseon, Fremont, California, United States of America
Affiliation Oryzon Genomics, S.A., Cornellà de Llobregat, Spain
- Nathalie Guibourt
-
Roles Investigation, Methodology, Writing – review & editing
Affiliation Oryzon Genomics, S.A., Cornellà de Llobregat, Spain
- Fernando Cavalcanti
-
Roles Formal analysis, Investigation, Supervision, Writing – original draft, Writing – review & editing
Affiliation Oryzon Genomics, S.A., Cornellà de Llobregat, Spain
- Christian Griñan-Ferré
-
Roles Formal analysis, Investigation, Resources, Writing – review & editing
Affiliation Faculty of Pharmacy and Food Sciences, Institute of Neuroscience, University of Barcelona, Barcelona, Spain
- Mercè Pallàs
-
Roles Formal analysis, Investigation, Resources, Supervision, Writing – review & editing
Affiliation Faculty of Pharmacy and Food Sciences, Institute of Neuroscience, University of Barcelona, Barcelona, Spain
- Roser Nadal
-
Roles Formal analysis, Investigation, Resources, Writing – review & editing
Affiliation Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain
- Antonio Armario
-
Roles Formal analysis, Investigation, Resources, Writing – review & editing
Affiliation Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, Spain
- Isidro Ferrer
-
Roles Formal analysis, Investigation, Methodology, Resources, Writing – review & editing
Affiliation Institut de Neuropatologia, Servei Anatomia Patologica, IDIBELL-Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Spain
- Alberto Ortega
-
Roles Formal analysis, Investigation, Visualization, Writing – review & editing
Affiliation Oryzon Genomics, S.A., Cornellà de Llobregat, Spain
- Nuria Valls
-
Roles Formal analysis, Investigation, Writing – review & editing
Current Address: Alba-Cells, Cerdanyola del Vallès, Barcelona, Spain
Affiliation Oryzon Genomics, S.A., Cornellà de Llobregat, Spain
- Matthew Fyfe
-
Roles Conceptualization, Project administration
Current Address: Sitryx therapeutics, Oxford, United Kingdom
Affiliation Oryzon Genomics, S.A., Cornellà de Llobregat, Spain
- Marc Martinell
-
Roles Supervision, Writing – review & editing
Current Address: Minoryx, Mataró, Barcelona, Spain
Affiliation Oryzon Genomics, S.A., Cornellà de Llobregat, Spain
- Julio César Castro Palomino
-
Roles Conceptualization, Writing – review & editing
Current Address: Palobiofarma, Mataró, Barcelona, Spain
Affiliation Oryzon Genomics, S.A., Cornellà de Llobregat, Spain
- Carlos Buesa Arjol
-
Roles Conceptualization, Funding acquisition
Affiliation Oryzon Genomics, S.A., Cornellà de Llobregat, Spain
Competing Interests
I have read the journal's policy and the authors of this manuscript have the following competing interests: T.M. and C.B. are founders, executive directors and shareholders of Oryzon Genomics S.A.; C.M., D.R., M.M.P.L., AO, J.S. and E.C. are employees; and A.E., N.G., N.V., M.F., M.M. and J.C.C.P. are former employees of Oryzon Genomics S.A.; I.F. is former member of the SAB of Oryzon Genomics S.A. A.O., M.F., M.M., A.E., N.V, J.C.C.P., T.M., C.M., D.R., C.G.F, M.P., R.N., A.A., are listed as inventors on one or several of the following patent applications of Oryzon Genomics S.A. related to this work: WO2012/013728; WO2013/057320; WO2016/198649; WO2017/158136; WO2019/025588. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. This does not alter our adherence to PLOS ONE policies on sharing data and materials with the following exceptions: Polyphemous, proprietary software of Oryzon Genomics S.A., is not available as an exportable .exe code.